The latest closing stock price for Intra-Cellular Therapies as of January 17, 2025 is 126.20.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,413 today, roughly 7 times their original investment - a 21.36% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 127.19 on January 13, 2025.
The Intra-Cellular Therapies 52-week high stock price is 128.00, which is 1.4% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 62.78, which is 50.3% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 75.56.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,413 today, roughly 7 times their original investment - a 21.36% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 127.19 on January 13, 2025.
The Intra-Cellular Therapies 52-week high stock price is 128.00, which is 1.4% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 62.78, which is 50.3% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 75.56.